Franck Pagès

Inserm — France

Medicine · Health Sciences

45h-index41.5kcitations234works7.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(148), Colorectal Cancer Treatments and Studies(49), Colorectal Cancer Surgical Treatments(41), Colorectal and Anal Carcinomas(35), Immunotherapy and Immune Responses(33)

Publications233 total

Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Journal of Clinical Oncology·2025· 15 citedOpen Access
Combining immunoscore and tumor budding in colon cancer: an insightful prognostication based on the tumor-host interface
Journal of Translational Medicine·2024· 6 citedOpen Access
7MO Combined analyses of ctDNA and Immunoscore in stage III colon cancer patients: A post hoc analysis of the IDEA-France and -Greece trials
Annals of Oncology·2024Open Access
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies
Journal of Clinical Oncology·2024· 23 citedOpen Access
Reply to Z. Gao et al
Journal of Clinical Oncology·2024
Pembrolizumab in Combination with CAPOX and Bevacizumab in Patients with Microsatellite Stable Metastatic Colorectal Cancer and a High Immune Infiltrate: Preliminary Results of the Single-Arm, Phase II, Open-Label FFCD 1703-POCHI Trial
SSRN Electronic Journal·2024Open Access
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy
Journal of Clinical Oncology·2023· 39 citedOpen Access
Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore
Cancers·2023· 10 citedOpen Access
Figure S3 from Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
2023Open Access
Data from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Figure 2 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Figure S2 from Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
2023Open Access
Table S2 from Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
2023Open Access
Table S3 from Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
2023Open Access
Data from A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
2023Open Access
Supplementary Figure 1 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Tables 1 - 5 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Figure 2 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Supplementary Tables 1 - 5 from Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2023Open Access
Table S2 from Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Jérôme Galon(41), Wolf H. Fridman(25), Bernhard Mlecnik(23), Amos Kirilovsky(21), Gabriela Bindea(20), Anne Berger(18), Florence Marliot(15), Tessa Fredriksen(11), Marie Tosolini(10), Patrick Bruneval(10), Zlatko Trajanoski(9), Nacilla Haicheur(9), Lucie Lafontaine(8), Marc Van den Eynde(8), Helen K. Angell(7), Carine El Sissy(7), Christine Lagorce(7), Paolo A. Ascierto(7), Bernard A. Fox(7), Catherine Sautès‐Fridman(6)